XML 105 R76.htm IDEA: XBRL DOCUMENT v3.6.0.2
Acquisitions and Divestitures - 2015 Acquisitions - Additional Information (Detail)
$ / shares in Units, € in Millions
 1 Months Ended 3 Months Ended 4 Months Ended 5 Months Ended 12 Months Ended 14 Months Ended
Oct. 05, 2016
shares
Apr. 30, 2016
USD ($)
Jul. 31, 2015
USD ($)
$ / shares
shares
Jul. 23, 2015
shares
Jul. 22, 2015
shares
Apr. 30, 2016
USD ($)
Jul. 31, 2015
USD ($)
$ / shares
Jul. 30, 2015
shares
Mar. 31, 2015
USD ($)
Employees
Mar. 31, 2015
EUR (€)
Employees
Dec. 31, 2016
USD ($)
Sep. 30, 2016
USD ($)
Jun. 30, 2016
USD ($)
Mar. 31, 2016
USD ($)
Dec. 31, 2015
USD ($)
Sep. 30, 2015
USD ($)
Jun. 30, 2015
USD ($)
Mar. 31, 2015
USD ($)
Apr. 29, 2016
USD ($)
Employees
Dec. 31, 2015
USD ($)
Dec. 31, 2016
USD ($)
Tranche
shares
Dec. 31, 2015
USD ($)
Dec. 31, 2014
USD ($)
Employees
Oct. 04, 2016
shares
Mar. 31, 2015
EUR (€)
Mar. 06, 2015
$ / shares
Business Acquisition [Line Items]                                                    
Gain from sale of Remmele Medical business   $ 0       $ 0                                        
Sale generated in last annual period prior to divestiture                     $ 2,967,000,000 $ 3,138,000,000 $ 3,234,000,000 $ 3,055,000,000 $ 2,991,000,000 $ 3,127,000,000 $ 3,204,000,000 $ 3,091,000,000     $ 12,394,000,000 $ 12,413,000,000 $ 12,542,000,000      
Goodwill                     5,148,000,000       5,249,000,000         $ 5,249,000,000 5,148,000,000 5,249,000,000 5,087,000,000      
Common stock conversion transaction value                             $ 870,000,000         870,000,000   870,000,000 610,000,000      
After-tax operating income (ATOI)                                         1,087,000,000 $ 986,000,000 983,000,000      
Goodwill [Member]                                                    
Business Acquisition [Line Items]                                                    
Increase (decrease) intangible assets   $ (44,000,000)                                                
LISI MEDICAL [Member]                                                    
Business Acquisition [Line Items]                                                    
Cash received on sale of operations           102,000,000                                        
Sale of Remmele Medical business, net of transaction costs           $ 99,000,000                                        
TITAL [Member]                                                    
Business Acquisition [Line Items]                                                    
Number of employees | Employees                 650 650                                
Cash paid for business acquisition                 $ 204,000,000 € 188                                
Business acquisition transaction cost                 1,000,000                 1,000,000             € 1  
Goodwill                 $ 118,000,000                 $ 118,000,000                
RTI [Member]                                                    
Business Acquisition [Line Items]                                                    
Sale generated in last annual period prior to divestiture                                     $ 20,000,000       $ 794,000,000      
Number of employees | Employees                                     330       2,600      
Goodwill                     298,000,000                   298,000,000          
Common stock conversion transaction value     $ 870,000,000       $ 870,000,000                                      
Business acquisition common stock issued, price per share | $ / shares     $ 9.96       $ 9.96                                     $ 14.48
Number of shares to be issued upon conversion | $ / shares     $ 2.8315       $ 2.8315                                      
Acquisition price per share | $ / shares                                                   $ 41
Number of common stock shares issued in a part of acquisition | shares 29,000,000   29,000,000 87,397,414 29,132,471     87,000,000                               87,000,000    
Professional fees and costs             $ 25,000,000                                      
Professional fees and costs, after tax             $ 19,000,000                                      
Third-party sales                                       309,000,000            
Goodwill deductible for income tax purpose                     $ 0                   $ 0          
RTI [Member] | Convertible Notes [Member]                                                    
Business Acquisition [Line Items]                                                    
Number of repayment tranches | Tranche                                         2          
Convertible debt, due date of first tranche                                         Dec. 01, 2015          
Convertible debt, due date of second tranche                                         Dec. 31, 2019          
Conversion of notes to common stock | shares                                         14,156,000          
RTI [Member] | Maximum [Member]                                                    
Business Acquisition [Line Items]                                                    
After-tax operating income (ATOI)                                       $ (1,000,000)